Ascendis Pharma A/S (ASND)
Ascendis Pharma Market Cap : 14.26B for Feb. 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novo Nordisk A/S | 177.67B |
| Evaxion AS | 27.11M |
| DBV Technologies SA | 1.156B |
| Cellectis SA | 397.33M |
| Biodexa Pharmaceuticals Plc | 0.9898M |
Market Cap Related Metrics
| PS Ratio | 17.12 |
| Price to Free Cash Flow | 273.97 |
| Price | 232.39 |
| Earnings Yield | -1.81% |